FOUNDATIONS IN Neonataland Pediatric Respiratory Care Teresa A.Volsko Sherry Barnhart

content, statements, views, and opinions herein are the sole expression of the respective authors and not that of Jones & Bartlett Learning, LLC.
Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not constitute
or imply its endorsement or recommendation by Jones & Bartlett Learning, LLC and such reference shall not be used for advertising or product
endorsement purposes. All trademarks displayed are the trademarks of the parties noted herein. Foundations in Neonatal and Pediatric Respiratory
Care is an independent publication and has not been authorized, sponsored, or otherwise approved by the owners of the trademarks or service
marks referenced in this product.
There may be images in this book that feature models; these models do not necessarily endorse, represent, or participate in the activities
represented in the images. Any screenshots in this product are for educational and instructive purposes only. Any individuals and scenarios
featured in the case studies throughout this product may be real or fictitious, but are used for instructional purposes only.
The authors, editor, and publisher have made every effort to provide accurate information. However, they are not responsible for errors,
omissions, or for any outcomes related to the use of the contents of this book and take no responsibility for the use of the products and
procedures described. Treatments and side effects described in this book may not be applicable to all people; likewise, some people may require a
dose or experience a side effect that is not described herein. Drugs and medical devices are discussed that may have limited availability controlled
by the Food and Drug Administration (FDA) for use only in a research study or clinical trial. Research, clinical practice, and government
regulations often change the accepted standard in this field. When consideration is being given to use of any drug in the clinical setting, the health
care provider or reader is responsible for determining FDA status of the drug, reading the package insert, and reviewing prescribing information
for the most up-to-date recommendations on dose, precautions, and contrain

Добавить комментарий

Ваш адрес email не будет опубликован. Обязательные поля помечены *